Clément Dumont

434 total citations
37 papers, 207 citations indexed

About

Clément Dumont is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clément Dumont has authored 37 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clément Dumont's work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Clément Dumont is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Clément Dumont collaborates with scholars based in France, United States and Spain. Clément Dumont's co-authors include Nathalie Rouas‐Freiss, Edgardo D. Carosella, Joël LeMaoult, François Desgrandchamps, Jérôme Verine, Stéphane Culine, Ching‐Lien Wu, Floriane Noël, Yohann Loriot and Pernelle Lavaud and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Clément Dumont

30 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clément Dumont France 9 87 68 50 37 35 37 207
Kalpana Devaraj United States 5 24 0.3× 64 0.9× 37 0.7× 64 1.7× 68 1.9× 9 216
Jessica Mariel Sierra Argentina 7 192 2.2× 125 1.8× 24 0.5× 15 0.4× 35 1.0× 10 276
Giorgia Trevisan United Kingdom 7 29 0.3× 54 0.8× 24 0.5× 44 1.2× 25 0.7× 11 143
Sandrine Richard France 8 18 0.2× 100 1.5× 46 0.9× 30 0.8× 39 1.1× 22 188
Charlotte H. J. R. Jansen Netherlands 9 35 0.4× 36 0.5× 9 0.2× 21 0.6× 56 1.6× 17 237
Daron Street United States 8 47 0.5× 88 1.3× 64 1.3× 36 1.0× 68 1.9× 11 271
Iris Wang United States 6 59 0.7× 100 1.5× 31 0.6× 11 0.3× 23 0.7× 13 148
Carlos Linn United States 6 96 1.1× 198 2.9× 87 1.7× 27 0.7× 34 1.0× 15 283
Zhongqiu Lin China 10 47 0.5× 89 1.3× 21 0.4× 28 0.8× 143 4.1× 19 254
David García-Illescas Spain 6 27 0.3× 71 1.0× 53 1.1× 31 0.8× 35 1.0× 15 156

Countries citing papers authored by Clément Dumont

Since Specialization
Citations

This map shows the geographic impact of Clément Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clément Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clément Dumont more than expected).

Fields of papers citing papers by Clément Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clément Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clément Dumont. The network helps show where Clément Dumont may publish in the future.

Co-authorship network of co-authors of Clément Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of Clément Dumont. A scholar is included among the top collaborators of Clément Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clément Dumont. Clément Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auclin, Édouard, Clément Dumont, H. Gauthier, et al.. (2026). Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 24(2). 102506–102506.
2.
Dumont, Clément, Guilhem Roubaud, Damien Pouessel, et al.. (2025). Feasibility and efficacy of cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer in older patients: A retrospective French GETUG study.. Journal of Clinical Oncology. 43(5_suppl). 735–735.
3.
Faouzi, Sara, Léonor Chaltiel, Clément Dumont, et al.. (2025). Treatment of poor-risk non seminomatous germ-cell tumors (NSGCT) adapted by tumor marker decline: A 7-year multicenter real-world experience.. Journal of Clinical Oncology. 43(16_suppl). 5034–5034.
4.
Auclin, Édouard, Anna Patrikidou, Laura Mezquita, et al.. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 15(4). 1066–1066. 10 indexed citations
5.
Gauthier, Hélène, Christophe Hennequin, Évanguelos Xylinas, et al.. (2023). Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer. World Journal of Urology. 41(11). 3249–3255. 5 indexed citations
7.
Dumont, Clément, et al.. (2023). Chimiothérapie préopératoire des tumeurs des voies excrétrices supérieures : impact sur la fonction rénale. Progrès en Urologie. 33(8-9). 446–455. 1 indexed citations
8.
Dumont, Clément, Hélène Gauthier, Christophe Hennequin, et al.. (2023). Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patients. World Journal of Urology. 41(10). 2715–2722. 1 indexed citations
9.
Colomba, Émeline, Luca Campedel, Clément Dumont, et al.. (2022). Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. Cancers. 14(7). 1678–1678. 7 indexed citations
10.
Mestrallet, Guillaume, Clément Dumont, Fatiha Bouhidel, et al.. (2022). Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies. Frontiers in Oncology. 12. 898732–898732. 12 indexed citations
11.
Joly, Bérangère S., et al.. (2022). Disseminated Intravascular Coagulation with Enhanced Fibrinolysis Caused by Heart Metastasis of Bladder Urothelial Carcinoma. SHILAP Revista de lepidopterología. 15(2). 745–749. 1 indexed citations
12.
Epaillard, Nicolas, Yohann Loriot, Pernelle Lavaud, et al.. (2021). Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. Frontiers in Oncology. 11. 9 indexed citations
13.
Dumont, Clément, et al.. (2021). Palladium catalyzed telomerization of bio-based polyols with atmospheric pressure bubbling butadiene. Molecular Catalysis. 502. 111369–111369. 4 indexed citations
14.
Delattre, Jean-François, Jérôme Verine, Clément Dumont, et al.. (2021). Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients. Cancer Letters. 519. 105–116. 14 indexed citations
15.
Barthélémy, Philippe, Clément Dumont, Brigitte Laguerre, et al.. (2020). 735P Metastatic renal medullary and collecting duct carcinoma in the era of antiangiogenic and immune checkpoint inhibitors: A multicentric retrospective study. Annals of Oncology. 31. S574–S574. 3 indexed citations
17.
Dumont, Clément, et al.. (2020). Cytometry-based analysis of HLA-G functions according to ILT2 expression. Human Immunology. 81(4). 168–177. 12 indexed citations
18.
Dumont, Clément, Giulia Baciarello, Pernelle Lavaud, et al.. (2020). Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial. Clinical Genitourinary Cancer. 18(6). 444–451. 6 indexed citations
19.
Dumont, Clément, Jérôme Verine, Floriane Noël, et al.. (2019). CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G. Cancer Immunology Research. 7(10). 1619–1632. 53 indexed citations
20.
Cohen, Romain, Pascale Cervera, Magali Svrcek, et al.. (2015). [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].. 102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026